Belden Ranked as a Top Five Stock on the Argent St. Louis Stock Index
Transformation and solutions focus cited as the core reasons for the positive results ST. LOUIS–(BUSINESS…
Transformation and solutions focus cited as the core reasons for the positive results ST. LOUIS–(BUSINESS…
Elanco announces UpLook™ Insights Engine for Sustainable Progress Elanco announces the creation of Athian, a…
NEW YORK–(BUSINESS WIRE)–BTIG announced today that Alex Alden has joined the firm as a Managing…
NEW YORK–(BUSINESS WIRE)–Blackstone Secured Lending Fund (NYSE:BXSL) (the “Company”) announced today that it will host…
HOUSTON–(BUSINESS WIRE)–$CRGY–Crescent Energy Company (NYSE: CRGY) (“we” or “our”) announced today that, subject to market…
PLEASANTON, Calif.–(BUSINESS WIRE)–Global branded payments provider Blackhawk Network has expanded its longtime partnership with Kroger…
The Facility Provides RumbleOn Customers Unprecedented Access to Company-Originated Financing, Furthering RumbleOn’s Commitment to Enhancing…
TORONTO, Feb. 07, 2022 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the…
SEATTLE and CAMBRIDGE, United Kingdom, Feb. 07, 2022 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc. (Nasdaq:…
AUSTIN, Texas, Feb. 07, 2022 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
CHATHAM, N.J., Feb. 07, 2022 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix…
BOSTON and LONDON, Feb. 07, 2022 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader,…
EDP1815 led to significantly lower production of IL-6, IL-8 and TNF Data announced by Evelo…
PHILADELPHIA, Feb. 07, 2022 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology…
Quarterly investor call and webcast scheduled for Monday, February 14 at 8:00 a.m. ET Roivant will…
BERKELEY HEIGHTS, N.J., Feb. 07, 2022 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ:…
– Data from two nonclinical studies evaluating protein expression and tolerability support future clinical development…
CAMBRIDGE, Mass., Feb. 07, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) today…
Orphazyme A/SInvestor NewsNo. 01/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, February 7, 2022 – Orphazyme…
$SFWJ – Software Effective Solutions Corporation Announces Acquisition of MedCana, Inc. MedCana Nature’s Bio Lab…